YHLO

Focus on healthcare, better life with technology In May of 2021, YHLO has successfully launched IPO and listed on Shanghai Stock Exchange (Stock code: 688575).

YHLO (EST. 2008) is an innovative and steadfastly growing company of immunoassay solutions headquartered in Shenzhen, China, specialized in developing, manufacturing and distributing in-vitro diagnostic instruments and reagents by a team of experienced scientists and engineers.

15/04/2026

iFlash HIV Combo cuts the window period by detecting p24 antigen alongside antibodies, and Anti-TP ensures accurate syphilis screening.

🔗 Learn more about YHLO: https://en.szyhlo.com

14/04/2026

Meet YHLO PIFI: Smarter Islet Function Assessment

Launched on April 10 at the 2026 Islet Metabolism Forum in Nanjing, the YHLO PIFI Intelligent Computing Model marks a major step forward in diabetes care.

💡 Two highlights:
- Built on clinical practice data from over 10,000 Chinese cases
- Delivers a dual leap in algorithmic accuracy and clinical adaptability

💡 Three systemic transformations:
- Quantifiable, classifiable, traceable islet function: powered by big data and population stratification.
- Seamlessly integrated into clinical workflows: supporting physicians, boosting efficiency, without extra burden.
- Full-cycle management from screening to followup: driven by physician-patient collaboration and data accumulation.

10,000+ cases. One intelligent leap. 💪
PIFI makes islet function measurable and meaningful.

(*This model is not yet available for clinical diagnosis.)

🔗 Learn more about YHLO: https://en.szyhlo.com

10/04/2026

Hepatitis Screening | Streamlined by iFlash CLIA

- Complete coverage: HBsAg, Anti-HBs, HBeAg, Anti-HBe, Anti-HBc, Anti-HCV
- Operational convenience: efficient routine screening with minimal hands-on time
- Reliable Performance: stable, reliable analytical performance in several scenrios

🏆 YHLO is the first Chinese company to achieve full IVDR CE certification for the complete Blood Bank Panel, including including HIV, HBV(HBsAg, Anti-HBs, HBeAg, Anti-HBe, Anti-HBc), HCV, and Syphilis(Anti-TP).

🔗 Learn more about YHLO:https://en.szyhlo.com

07/04/2026

World Health Day 2026: Together for Health, Stand with Science

Health begins with clarity — accurate, timely, accessible.
This , we honor the laboratories, clinicians, and systems that turn diagnostics into care. And we reaffirm our commitment to supporting them, every step of the way.

06/04/2026

We leave with full hearts and clearer minds.
Grateful for every partner who made the trip, shared their voice, and believed in what we are building together.✨🎉

Watch the highlights and relive the energy. 🎥👇

🔗Learn more about YHLO: https://en.szyhlo.com

02/04/2026

2026 YHLO Global Partners Conference: Intelligent Automation · Infinite Potential

Thank you to every partner who joined us. What meaningful conversations, shared vision, and renewed commitment.

🎤 Conference & Forum: Thank you to every speaker and participant who shared their insights. We are excited to move forward with our global partners, exploring new possibilities and a future full of promise.
🏆 Awards: With deep gratitude, we honored our long-standing partners with the "Lasting Trust Partner." Thankful for the contributions that truly stand out.
🎆 Welcome Gala: The evening began with a warm address from our founder, Mr. Hu Deming, setting the tone for a night of connection and celebration. Over dinner and performances, we shared laughter, conversation, and the simple joy of being together.
⚙️ Industrial Park Visit: We were proud to welcome our partners to our new manufacture center in Xiangtan city - a 150-mu (approx. 10-hectare) facility backed by over RMB 1 billion in investment. As a strategic hub for intelligent manufacturing, it now houses the production of our iTLA Max automation system and high-speed biochemistry analyzers - bringing innovation from design to scale under one roof.

The conference may have ended, but the collaboration continues. 💪 🤝

🔗 Learn more about YHLO: https://en.szyhlo.com

31/03/2026

When Total Testosterone Isn't Enough: Free Testosterone from YHLO

Free Testosterone is not simply a calculation — it is a clinically distinct parameter with unique value across the lifespan.

✅In Men: Accurate diagnosis of late-onset hypogonadism (LOH) — where total testosterone may remain within range, but the free testosterone fraction can provide more meaningful insights.
✅In Women: The most sensitive marker for diagnosing hyperandrogenism — capturing biologically active androgens that total measurements miss.
✅In Children: Supports differentiation between precocious and delayed puberty — offering insight into true gonadal activity.

Free Testosterone from YHLO will be available soon — completing the androgen picture for clinicians who need more than total testosterone alone.

🔗 Learn more about YHLO: https://en.szyhlo.com

30/03/2026

YHLO Antiphospholipid Syndrome Panel: Beyond Presence, Toward Risk

Antiphospholipid syndrome (APS) is not defined by a single antibody — but by the interplay of multiple isotypes and specificities. Clinical evaluation demands a broad view.

🔹 YHLO's comprehensive panel covers guideline-recommended markers:
- Cardiolipin IgG · Cardiolipin IgM · β2-Glycoprotein I IgG · β2- Glycoprotein IgM and provides supplementary markers of Cardiolipin IgA
- Anti-Cardiolipin · β2-Glycoprotein IgA · Anti-β2-Glycoprotein I, to further improve the detection rate.

At YHLO, we help clinicians see beyond individual antibodies — toward clearer risk assessment and better-informed decisions.

🔗 Learn more about YHLO: https://en.szyhlo.com

27/03/2026

Total β-HCG: From Early Pregnancy to Tumor Monitoring🤰🎗️

Total β-HCG is one of the most versatile markers in clinical practice — offering insights that extend far beyond early pregnancy.

✅In Obstetrics & Gynecology:
- Early pregnancy diagnosis: the first indicator of gestation
- Differentiation of ectopic pregnancies from intrauterine pregnancies
- Miscarriage monitoring: trending levels guide clinical decisions

✅In Oncology:
- Trophoblastic tumors: essential for diagnosis and treatment monitoring
- Germ cell tumors: a key marker in certain subtypes, supporting disease surveillance

One marker. Multiple critical roles. 💡

From early pregnancy to oncology — at YHLO, we help clinicians navigate the full diagnostic spectrum of Total β HCG. 🤝

🔗 Learn more about YHLO: https://en.szyhlo.com

26/03/2026

YHLO Androgen & Adrenal Function Parameters: Seeing PCOS More Clearly

PCOS affects fertility, metabolism, and long-term health. At its core lies androgen dysregulation that requires a fuller picture to assess.

🔹 YHLO's expanding panel offers clinicians a set of essential tools for a more complete assessment:
DHEA-S · 17α-OH-P · Androstenedione · SHBG · Free Testosterone** (**Coming Soon)

✔️ This panel supports clinicians in:
- Distinguish between ovarian and adrenal sources
- Support the diagnosis and subtyping of PCOS
- Guide more targeted treatment decisions

🔗 Learn more about YHLO: https://en.szyhlo.com

24/03/2026

World Tuberculosis Day: Yes! We Can End TB.🌍💪

TB remains one of the world's deadliest infectious diseases. Ending TB builds stronger, more resilient health systems, a critical investment in national and global health security.

Early detection changes everything. 🔍✅It interrupts transmission, enables cure, and preserves futures.

Today, we stand with everyone working to turn the tide — clinicians on the front lines, researchers pushing boundaries, and communities reaching those most at risk.

Ending TB is not just aspirational — it is achievable. And together, we can make it.🌍✨

21/03/2026

World Down Syndrome Day: Stand Together Against Loneliness

Down syndrome is a condition that is characterised by an extra chromosome. Down syndrome occurs naturally and there is currently no known cause. It is estimated that approximately one in every 800 babies is born with the condition.👶🌍

Today, we stand in solidarity with individuals with Down syndrome, their families, and all those who strive for a world where inclusion is the standard, not the exception.🤝🏡

Every person deserves to be seen, heard and valued — for who they are and for all they bring to our communities.👀👂❤️

On the occasion of , we are committed to promoting inclusion, respect and the value of every life.

Address

YHLO Biopark, Baolong 2nd Road, Baolong Subdistrict
Shenzhen
518000

Telephone

+8675526601910

Website

https://en.szyhlo.com/

Alerts

Be the first to know and let us send you an email when YHLO posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to YHLO:

Shortcuts

Want your practice to be the top-listed Clinic in Shenzhen?